Literature DB >> 31160977

Cytotoxic effect of protic ionic liquids in HepG2 and HaCat human cells: in vitro and in silico studies.

Bruna Varela Zanoni1, Gabriela Brasil Romão2, Rebecca S Andrade3, Regina Maria Barretto Cicarelli4, Eliane Trovatti1, Bruna Galdorfini Chiari-Andrèo1,4, Miguel Iglesias2.   

Abstract

Protic ionic liquids (PILs) are innovative chemical compounds, which due to their peculiar nature and amazing physico-chemical properties, have been studied as potential sustainable solvents in many areas of modern science, such as in the industrial fields of textile dyeing, pharmaceuticals, biotechnology, energy and many others. Due to their more than probable large-scale use in a short space of time, a wider analysis in terms of ecotoxicity and biological safety to humans has been attracting significant attention, once many ionic liquids were found to be "a little less than green compounds" towards cells and living organisms. The aim of this study is to investigate the cytotoxicity of 13 recently synthesized PILs, as well as to reinforce knowledge in terms of key thermodynamic magnitudes. All the studied compounds were tested for their in vitro toxic activities on two human cell lines (normal keratinocytes HaCaT and hepatocytes HepG2). In addition, due to the enormous number of possible combinations of anions and cations that can form ionic liquids, a group contribution QSAR model has been tested in order to predict their cytotoxicity. The estimated and experimental values were adequately correlated (correlation coefficient R 2 = 0.9260). The experimental obtained results showed their remarkable low toxicity for the studied in vitro systems.

Entities:  

Year:  2019        PMID: 31160977      PMCID: PMC6505392          DOI: 10.1039/c8tx00338f

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  18 in total

Review 1.  Maintenance of genomic integrity in mammalian kidney cells exposed to hyperosmotic stress.

Authors:  D Kültz; D Chakravarty
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2001-10       Impact factor: 2.320

2.  Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts.

Authors:  Martin B Friis; Christel R Friborg; Linda Schneider; Maj-Britt Nielsen; Ian H Lambert; Søren T Christensen; Else K Hoffmann
Journal:  J Physiol       Date:  2005-06-23       Impact factor: 5.182

Review 3.  Apoptosis: a review of programmed cell death.

Authors:  Susan Elmore
Journal:  Toxicol Pathol       Date:  2007-06       Impact factor: 1.902

4.  Comparative physiology of salt and water stress.

Authors:  R. Munns
Journal:  Plant Cell Environ       Date:  2002-02       Impact factor: 7.228

5.  Apoptosis induced by hypertonicity in Madin Darley canine kidney cells: protective effect of betaine.

Authors:  M Horio; A Ito; Y Matsuoka; T Moriyama; Y Orita; M Takenaka; E Imai
Journal:  Nephrol Dial Transplant       Date:  2001-03       Impact factor: 5.992

6.  Evaluating the cytotoxicity of ionic liquids using human cell line HeLa.

Authors:  P Stepnowski; A C Składanowski; A Ludwiczak; E Laczyńska
Journal:  Hum Exp Toxicol       Date:  2004-11       Impact factor: 2.903

7.  Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.

Authors:  Stefan Wilkening; Frank Stahl; Augustinus Bader
Journal:  Drug Metab Dispos       Date:  2003-08       Impact factor: 3.922

8.  Water-immiscible room temperature ionic liquids (RTILs) as drug reservoirs for controlled release.

Authors:  Vikas Jaitely; Aysegül Karatas; Alexander T Florence
Journal:  Int J Pharm       Date:  2008-01-24       Impact factor: 5.875

9.  Response of human cells to desiccation: comparison with hyperosmotic stress response.

Authors:  Zebo Huang; Alan Tunnacliffe
Journal:  J Physiol       Date:  2004-05-14       Impact factor: 5.182

10.  Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis.

Authors:  Ying Zhang; Li-Jun Wu; Shin-Ichi Tashiro; Satoshi Onodera; Takashi Ikejima
Journal:  Acta Pharmacol Sin       Date:  2004-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.